MUMBAI, India, July 24 -- Intellectual Property India has published a patent application (202611060043 A) filed by Noida Institute Of Engineering Technology Pharmacy Institute on May 12, 2026, for A Pharmaceutical Composition For Metabolic Disorder Management.
Inventors include Dr. Swarupanjali Padhi; and Aparna Gupta.
The application for the patent was published on July 17, 2026, under issue no. 29/2026.
Abstract: The invention relates to a pharmaceutical composition for metabolic disorder management comprising an oral dosage body carrying separated functional fractions for carbohydrate response, lipid processing, and metabolic support. The composition includes protective barriers, release-controlling matrices, stabilizers, and pharmaceutically acceptable excipients arranged to reduce incompatibility and provide staged gastrointestinal release. The formulation may be prepared as a tablet, capsule, layered unit, or multiparticulate system. The composition supports coordinated management of metabolic imbalance while improving stability, dose uniformity, manufacturability, and patient convenience.
Disclaimer: Curated by HT Syndication.
